Skip to main content
. 2023 Jul 14;13:64. doi: 10.1186/s13613-023-01161-6

Fig. 2.

Fig. 2

A 28-day survival and B cumulative incidence of liberation of respiratory support in patients receiving HFNO compared to patients receiving ventilation. For survival the adjusted hazard ratio is shown. A shows survival in the first 28 days, and B shows survival until the day of extubation. The cumulative incidence of liberation from respiratory support is shown as unadjusted hazard ratio with center as random effect. CI confidence interval, HFNO high-flow nasal oxygen, HR hazard ratio